scholarly journals Visual Improvement following Continuous Positive Airway Pressure Therapy in Diabetic Subjects with Clinically Significant Macular Oedema and Obstructive Sleep Apnoea: Proof of Principle Study

Respiration ◽  
2012 ◽  
Vol 84 (4) ◽  
pp. 275-282 ◽  
Author(s):  
Rebecca H. Mason ◽  
Christine A. Kiire ◽  
Dawn C. Groves ◽  
Helen J. Lipinski ◽  
Alyson Jaycock ◽  
...  
2017 ◽  
Vol 131 (9) ◽  
pp. 834-837 ◽  
Author(s):  
V Pinto ◽  
P G Morselli ◽  
D Tassone ◽  
O Piccin

AbstractBackground:Madelung's disease is a rare disorder characterised by the presence of multiple, symmetric, non-capsulated fat masses in the face, neck and other areas of upper extremities. In some cases, severe clinical complications such as upper airway compression can occur.Case report:A 56-year-old man affected by Madelung's disease complained of snoring and severe daytime sleepiness. Polysomnography revealed severe obstructive sleep apnoea. An attempt to treat sleep apnoea by continuous positive airway pressure failed because of poor compliance. Functional expansion pharyngoplasty was carried out as an initial treatment. Marked improvement of neck movements and normalisation of somnographic parameters were observed at six months’ follow up.Conclusion:Patients with Madelung's disease should be examined carefully for potential obstructive sleep apnoea. Although continuous positive airway pressure remains the treatment of choice, specific surgery can be used in those patients who cannot tolerate continuous positive airway pressure therapy.


PLoS ONE ◽  
2021 ◽  
Vol 16 (6) ◽  
pp. e0252915
Author(s):  
Michael S. H. Chou ◽  
Natasha C. H. Ting ◽  
Nicole El-Turk ◽  
Zinta Harrington ◽  
Claudia C. Dobler

Background Little is known about the treatment burden experienced by patients with obstructive sleep apnoea (OSA) who use continuous positive airway pressure (CPAP) therapy. Participants 18 patients (33.3% males, mean age 59.7±11.8 years) with OSA who use CPAP therapy were interviewed. Methods Patients treated with CPAP for OSA at a tertiary hospital outpatient clinic in Sydney, Australia, were invited to participate in an interview in person or via phone. Semi-structured interviews were used to explore the treatment burden associated with using CPAP. The interviews were recorded, transcribed, and analysed using NVivo 12 qualitative analysis software. Results Four categories of OSA-specific treatment burden were identified: healthcare tasks, consequences of healthcare tasks, exacerbating and alleviating factors of treatment burden. Participants reported a significant burden associated with using CPAP, independently of how frequently they used their device. Common sources of their treatment burden included attending healthcare appointments, the financial cost of treatment, lifestyle changes, treatment-related side effects and general discomfort. Conclusions This study demonstrated that there is a significant treatment burden associated with the use of CPAP, and that treatment non-adherence is not the only consequence of treatment burden. Other consequences include relationship burden, stigma and financial burden. It is important for physicians to identify other negative impacts of treatment burden in order to optimise the patient experience.


Sign in / Sign up

Export Citation Format

Share Document